Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FUJSH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 17, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 60 tablets of Xtandi 80 mg, an oncology medication used in prostate cancer treatment. This award was issued without set-aside designation, reflecting DMS Pharmaceutical Group's competitive position in federal pharmaceutical procurement markets. The contract specifies a completion date of September 18, 2025, with performance conducted at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards demonstrating consistent delivery of specialized pharmaceutical products to Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FUJSH?
SPE2DB25FUJSH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FUJSH worth?
The government has obligated $4,170 on SPE2DB25FUJSH.
Is contract SPE2DB25FUJSH an order under another contract?
Yes. SPE2DB25FUJSH is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSH competed?
The extent of competition for SPE2DB25FUJSH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award